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Abstract
Background: This study was conducted to establish the minimal detectable change (MDC) and clinically important
differences (CIDs) of the physical category of the Stroke-Specific Quality of Life Scale in patients with stroke.
Methods: MDC and CIDs scores were calculated from the data of 74 participants enrolled in randomized
controlled trials investigating the effects of two rehabilitation programs in patients with stroke. These participants
received treatments for 3 weeks and underwent clinical assessment before and after treatment. To obtain test-
retest reliability for calculating MDC, another 25 patients with chronic stroke were recruited. The MDC was
calculated from the standard error of measurement (SEM) to indicate a real change with 95% confidence for
individual patients (MDC95). Distribution-based and anchor-based methods were adopted to triangulate the ranges
of minimal CIDs. The percentage of scale width was calculated by dividing the MDC and CIDs by the total score
range of each physical category. The percentage of patients exceeding MDC95 and minimal CIDs was also
reported.
Results: The MDC95 of the mobility, self-care, and upper extremity (UE) function subscales were 5.9, 4.0, and 5.3
respectively. The minimal CID ranges for these 3 subscales were 1.5 to 2.4, 1.2 to 1.9, and 1.2 to 1.8. The
percentage of patients exceeding MDC95 and minimal CIDs of the mobility, self-care, and UE function subscales
were 9.5% to 28.4%, 6.8% to 28.4%, and 12.2% to 33.8%, respectively.
Conclusions: The change score of an individual patient has to reach 5.9, 4.0, and 5.3 on the 3 subscales to
indicate a true change. The mean change scores of a group of patients with stroke on these subscales should
reach the lower bound of CID ranges of 1.5 (6.3% scale width), 1.2 (6.0% scale width), and 1.2 (6.0% scale width) to
be regarded as clinically important change. This information may facilitate interpretations of patient-reported
outcomes after stroke rehabilitation. Future research is warranted to validate these findings.
Background
Although the stroke mortality rate has been declining
[1], the estimated prevalence rate of stroke-related dis-
ability is about 331 per 100,000 [2]. Stroke disability and
morbidity cause reduced quality of life (QOL) among
stroke survivors [3]. The greater the disability, the lower
the QOL is [4]. With ongoing rehabilitation, however,
improvements in functional status are possible [5] and
contribute to increase QOL for stroke survivors. There-
fore, the assessment of stroke rehabilitation should
include disability and QOL domains, which are influ-
enced by the disease [6-9].
Generic QOL instruments such as the Medical Out-
comes Study Short-Form 36-item survey (SF-36) may
underestimate the effect of stroke [10]; therefore, dis-
ease-specific tools are considered more helpful in pro-
viding information about the difficulties that patients
with stroke may experience [7,11]. Because the
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any medium, provided the original work is properly cited.information from the patients’ perspective on the conse-
quences of disease and the therapeutic benefits is
considered critical in the evaluation of health care,
patient-reported outcome measures have been used to
supplement clinical decisions made from physician-
based outcome measures [12]. Of the stroke-specific
scales, the Stroke-Specific Quality of Life Scale (SS-QOL)
[13], in addition to the Stroke Impact Scale version 3.0
(SIS 3.0) [14], is the most comprehensive [15] and fre-
quently used patient-reported outcome measure [16-19].
The SS-QOL is a self-report questionnaire consisting
of 49 items in the 12 domains of energy, family roles,
language, mobility, mood, personality, self-care, social
roles, thinking, upper extremity (UE) function, vision,
and work/productivity. The domains are scored sepa-
rately, and a total score is also provided. The psycho-
metric properties of the SS-QOL have been validated in
patients with ischemic stroke and intracerebral hemor-
rhage [10,18,20]. In patients with subarachnoid hemor-
rhage, the 12 SS-QOL domains and the total score
demonstrated good internal consistency [21]. The SS-
QOL items also have acceptable agreement with the
categories of the International Classification of Func-
tioning, Disability, and Health, which indicates that the
SS-QOL covers multidimensional components meaning-
ful for patients with stroke [22]. The clinical utility of
the SS-QOL remains understudied, however, and several
clinimetric properties, such as the minimal detectable
change (MDC) and the clinically important difference
(CID) of the SS-QOL, have not yet been investigated.
This information helps inform clinical decision making
on the discontinuation or alteration of a treatment pro-
gram that aims to improve patients’ physical function.
The MDC is the smallest change that can be detected
by the instrument beyond measurement error. The CID
is a related concept that shows how much change can
be deemed as clinically important [23]. That is, CID is
the threshold score that a group of patients perceive as
noticeable. The MDC and CID facilitate the interpreta-
tion of treatment outcomes. For example, the study by
Lin et al [24] reported that a true change in the SIS
m o b i l i t ys u b s c a l et h a to c c u r safter rehabilitation needs
to show an increase of at least 15.1 points or the change
is likely due to an error in the measurement.
In some instances, CID scores do not exceed the
MDC scores but still convey information about whether
a patient group experienced a clinically important
change. In the study of Plummer et al [25], for example,
the improvement of 0.11 m/s in gait speed was lower
than the measurement error of 0.17 m/s reported by
Evans et al [26], indicating that the improvement of gait
speed might not be real and beyond measurement error.
H o w e v e r ,t h ec h a n g eo f0 . 1 1m / sg a i ts p e e di nt h e
Plummer et al [25] study ind i c a t e dt h a tt h i sp a t i e n t
group improved from the category of physiologic ambu-
latory to that of full-time home ambulatory, according
to the walking categories developed by Perry et al [27].
Without these important benchmarks against which the
clinical interpretation is based, clinicians may make
erroneous conclusions about the effect of a treatment.
Therefore, this study sought to establish the MDC and
CID score estimates of the SS-QOL subscales and assess
the proportion of patients’ change scores on the SS-
QOL subscales that exceeded the MDC and CID in a
cohort of patients with stroke who received rehabilita-
tion therapies.
Methods
Participants
The study protocol consisted of 2 parts. First, the CIDs
data were obtained from participants in randomized
controlled trials investigating the effects of 2 upper limb
training programs [28,29]. These participants were con-
secutively screened and recruited from 4 stroke rehabili-
tation units. Of 126 patients receiving the intervention
in these 2 randomized controlled trials, 74 completed
the SS-QOL and were included in the present study.
The second part of the study is related to MDC. To
obtain the test-retest reliability for calculating MCD
[30], we recruited 25 patients with chronic stroke from
another independent sample.
The inclusion and exclusion criteria for these 2 sam-
ples (74 patients for part 1 and 25 samples for part 2)
were the same. The inclusion criteria of this study
include: first-ever stroke, at least 6 months’ poststroke,
demonstration of Brunnstrom stage III or higher for the
proximal part of the affected upper limb [31], no serious
cognitive deficits (score >24 on the Mini Mental-State
Exam) [32], and no excessive spasticity at any joint of
the upper limb (score of ≤2 on the Modified Ashworth
Scale) [33].
Excluded were patients with physician-determined
major medical problems and severe aphasia that could
potentially confound the study results. This study was
approved by Chang Gung Memorial Hospital Human
Research Ethics Board (96-0252B) and National Taiwan
University Hospital Research Ethics Committee
(200903080R), and all participants signed the informed
consent forms.
Interventions and Procedures
Only the 74 participants received 1 of the 3 rehabilita-
tion programs: bilateral arm training (BAT), distributed
constraint-induced therapy (CIT), or conventional reha-
bilitation. Therapy in the BAT group emphasized simul-
taneous movement of the affected and the unaffected
upper limb. The distributed CIT group focused on
restriction of movement of the unaffected limb and
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rehabilitation group focused on neurodevelopment tech-
niques with an emphasis on functional task practice,
when possible. The interventions were provided at the
participating hospitals under the supervision of 3 certifi-
cated occupational therapists. The raters were blinded
to the participant group and trained to properly admin-
ister the outcome measures. Rater competence was
assessed by a senior certified occupational therapist. The
same rater administered the SS-QOL evaluation at the 2
different time points (baseline and after the 3-week
intervention) for each participant.
Outcome Measure
The SS-QOL contains 12 subscales (as detailed earlier)
with a total of 49 items derived from a series of focused
interviews with 34 ischemic stroke survivors [13]. Scor-
ing of the SS-QOL concerns the past week and is rated
on a 5-point Likert scale. Response options are scored
as 5 ("no help needed/no trouble at all/strongly dis-
agree”), 4 ("a little help/a little trouble/moderately dis-
agree”), 3 ("some help/some trouble/neither agree nor
disagree”), 2 ("a lot of help/a lot of trouble/moderately
agree”), and 1 ("total help/could not do it at all/strongly
agree”). The SS-QOL provides domain scores and a
summary score, with higher scores indicating better
function. The test-retest reliability, internal consistency,
construct, and convergent validity of the SS-QOL have
been ascertained in patients with stroke [10,18,21].
Furthermore, the Chinese version of SS-QOL demon-
strated adequate Rasch separation reliability and unidi-
mensionality [34]. Because the intervention focused on
the rehabilitation of the paretic arm and the improve-
ment of daily functioning, the CID scores based on phy-
sical-related subscales directly reflect the benefit of
motor intervention. As a result, we only reported the
MDC95 and CID of the SS-QOL subscales that are
related to physical function, including mobility, self-care,
and UE function [35].
Data Analysis
Estimation of MDC
The MDC is calculated by multiplying the standard
error of measurement (SEM) by 1.96 to correspond to
the 95% confidence interval and the square root of 2 to
adjust for sampling from 2 different measurements [36].
The SEM is estimated as the pooled standard deviation
(SD) of test-retest assessments multiplied by the square
root of (1 - r), where r is the intraclass correlation coef-
ficient (ICC) [37]. The ICC, a kind of test-retest reliabil-
ity, was determined using a set of independent data
from 25 patients in whom the SS-QOL assessment was
conducted 2 weeks apart. The ICC was calculated using
a 2-way mixed effect model, with a consistency
coefficient. MDC95 means one can be 95% confident
that a change score equal to or exceeding this threshold
is true and reliable and not just measurement error [23].
Estimation of CID
The distribution-based and the anchor-based approaches
were both used to determine the CIDs of the subscales
of the SS-QOL. The distribution-based CID estimate
was determined using the between-participant baseline
SD and the SEM within-participant methods to estimate
the CID scores [38]. An effect size is a standardized
measure of change over time and represents individual
change in terms of the number of pretest SDs. For
example, an effect size of 0.5 indicates an increase of 0.5
SD. Cohen [39] has provided benchmarks that serve to
guide the interpretations of effects size. According to
Ringash et al [40], CIDs are generally close to an effect
size of 0.2, and an effect size of 0.5 represents humans’
limitation in discrimination [41]. We chose 0.5 SD units
to estimate the minimal threshold of CIDs. The SD var-
ies with the heterogeneity of the sample and does not
take patient variability of change into consideration. The
SEM, which simultaneously incorporates both the sam-
ple’s reliability and variability into the formula and is
relatively sample-independent, is used as another indica-
tor of minimal CID [37].
The anchor-based CID estimate was calculated as the
mean change score on each SS-QOL subscale, corre-
sponding to patients who perceived overall increased
recovery of 10% to 15% in the Stroke Impact Scale
(SIS). We chose SIS as the anchor during the calculation
of CID estimates because the overall recovery ratings on
SIS directly reflect the participant’s viewpoint on the
health-related recovery [42,43].
Although there is no defined range of the change
score as to the determination of the CID group, several
previous studies have found the smallest change score
of 10% on the 100-mm visual analog scale (VAS) of
quality of sleep [44], 11% on the 100-point Pediatric
Evaluation of Disability Inventory (PEDI) [45], and 15%
on the 100-mm VAS of back pain [46]. In addition,
Duncan et al [47] suggested the clinically meaningful
improvement of the SIS global rating scale is within
10% to 15% change. Therefore, patients in the current
study were classified into the CID group if a 10% to
15% change was documented on their perceived overall
recovery from pretreatment to posttreatment and were
considered as having experienced a clinically important
change.
Furthermore, to assess the extent of patients’ changes
after interventions detected by the SS-QOL subscales,
the percentage of scale width was calculated by dividing
the MDC and CIDs by the total score range of each
physical category. For example, the score range of the
mobility subscale was from 6 to 30, the total score
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proportions of patients with change scores greater than
the MDC95 values and the minimal threshold of CID
estimates were calculated.
Results
Table 1 presents the demographic and clinical charac-
teristics of the 74 patients enrolled in this study as well
as the additional 25 patients from the independent sam-
ple for calculating test-retest reliability. All characteris-
tics were comparable between these 2 samples, and
there were no preexisting differences between the 2
samples on any of the variables.
A si n d i c a t e di nT a b l e2t h eM D C 95 of the mobility,
self-care, and UE function subscales were 5.9 (24.6%
scale width), 4.0 (20.0% scale width), and 5.3 (26.5%
scale width), respectively. According to anchor-based
and distribution-based methods, we suggest the respec-
tive group-level CIDs for these 3 subscales are in range
of 1.5 to 2.4 (6.3% to 10% scale width), 1.2 to 1.9 (6.0%
to 9.5% scale width), and 1.2 to 1.8 (6.0% to 9.0% scale
width) for the mobility, self-care, and UE function sub-
scales, respectively. As reported in Table 3 an estimated
9.5%, 6.8%, and 12.2% of the patients had a positive
change that exceeded the MDC95 of the mobility, self-
care, and UE function subscales, and 28.4%, 28.4%, and
33.8% of patients’ change scores exceeded the lower
bound of CID ranges of the mobility, self-care, and UE
function subscales, respectively.
Discussion
To the best of our knowledge, this is the first study to
determine the MDC and CID scores of the SS-QOL
subscales that can be used to differentiate patients trea-
ted with stroke rehabilitation who experience real
improvement and clinically meaningful change from
those who do not. Our findings suggest that a patient’s
change score has to reach 5.9, 4.0, and 5.3 on the mobi-
lity, self-care, and UE function subscales to indicate a
true change. That is, when the change scores between
the patient’s 2 measurements (e.g., baseline and follow-
up) reach 24.6%, 20.0%, and 26.5% of the scale width on
the mobility, self-care, and UE function subscales, the
clinicians may interpret the changes in that patient as
true and reliable, given the 95% confidence level.
There is no universally accepted standard for deter-
mining the CID [48-52]. An integrated system for defin-
ing CID is recommended that combines anchor-based
and distribution-based methods [48]. The value and lim-
itations of anchor-based and distribution-based methods
in estimating CID have been recognized. The anchor-
based approach emphasizes the primacy of a patient’s
perspective, but anchor-based CID scores may vary with
demographic characteristics such as age [49]. Although
the distribution-based CID scores are easy to generate,
these SD-based scores are associated with some bias due
to sample heterogeneity [38]. As a result, a number of
recent clinical reports have advocated an approach that
combines the anchor-based and distribution-based
methods to refine the range of CID [24,50,51].
Using a 1 SEM distribution-based approach, we found
that the CIDs for the mobility, self-care, and UE func-
tion subscales are 1.7 (7.1% scale width), 1.2 (6.0% scale
width), and 1.3 (6.5% scale width), respectively. The
SEM incorporates a sample’s variability and the reliabil-
ity of the instrument. Several previous studies have
shown that 1 SEM is close to the estimate of CID
[53-56]. Despite being theoretically constant [56], the
SEM may become larger with a low reliability [57].
Furthermore, the CID scores using 1 SEM would be
always less than the MDC values mathematically. There-
fore, values of 0.5 SD were calculated as supportive
information for determining the CID. On the basis of
the 0.5 SD approach, we found that the CID scores for
the subscales were 2.4 (10% scale width) for mobility,
1.9 (9.5% scale width) for self-care, and 1.8 (9% scale
width) for UE function.
The CID values produced by the anchor-based method
were 1.5 (6.3% scale width) for mobility, 1.3 (6.5% scale
width) for self-care, and 1.2 (6.0% scale width) for UE
function. These estimates we r ec o m p a r a b l ew i t ht h o s e
obtained from the distribution-based approaches.
Because a cutoff threshold of the group-level CID may
Table 1 Demographic and baseline clinical characteristics
of the participants
Characteristic n
a =7 4 n
b =2 5 P
Age, mean (SD) y 57.1
(11.7)
52.9
(11.2)
0.89
c
Gender, Male/Female, No. 52/22 17/8 1.00
d
Months after stroke, mean (SD) 18.1
(16.4)
15.5
(12.8)
0.82
c
Side of stroke, Right/Left, No. 38/36 16/9 0.25
d
Stroke subtype, Hemorrhagic/Ischemic, No. 28/46 12/13 0.49
d
Brunnstrom stage of proximal UE, median
(range)
4.5 (3-6) 4 (3-6) 0.61
d
Fugl-Meyer Assessment UE scores, mean
(SD)
44.0
(13.1)
40.8
(14.1)
0.23
c
Mini Mental-State Exam scores, mean (SD) 27.5 (2.3) 26.6 (2.8) 0.23
c
Intervention, No.
Bilateral Arm Training 22
Constraint-Induced Therapy 16
Conventional Rehabilitation. 36
Abbreviations: SD, standard deviation; UE, upper extremity.
a The participants used for estimating clinically important differences;
b The
participants used for estimating the test-retest reliability;
c The two-sample
t-test, 2-tailed;
d Chi-square.
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data [58], we reported ranges rather than a single value.
We found the CID ranges were 1.5 to 2.4 for mobility,
1.2 to 1.9 for self-care, and 1.2 to 1.8 for UE function.
That is, patients with stroke who achieve mean scores in
the ranges of 6.3% to 10.0%, 6.0% to 9.5%, and 6.0% to
9.0% of the scale width on the mobility, self-care, and UE
function subscales are likely to have clinically meaningful
change in these domains.
Of note, there is a concern about the differences
between group and individual clinical importance [59].
Average effects across a group may not be meaningful
to the individual patient. Group-derived CID values are
suitable to interpret the results of clinical trials or group
studies, but they are often directly applied to interpret
the individual’s change [59]. For individual-level use, it
may be reasonable to expect that the MDC would be
less than or equal to the minimal CID. However, some
researchers have suggested that this is not always the
case [24,60], which is also consistent with our current
findings. When the MDC exceeds the minimal CID, the
change score reaching a CID does not mean that
patients have exceeded the measurement error, and
both values are suggested to be considered in clinical
decision making [61].
Taking our cohort sample of stroke rehabilitation as
an example, the mean change scores on the mobility,
self-care, and UE function subscales were 3.5, 2.8, and
4.1 points, which exceeded the minimal CID ranges.
This indicated that the improvements achieved after
rehabilitative therapies in this cohort were meaningful
to the patients. A mean change score of 1.2 on the self-
care subscale in a previous study of the Chronic Disease
Self-Management course [17] was reported to achieve
statistical significance. This improvement at the group
level failed to achieve the lower bound of the minimal
CID range established by our current study, which may
w e a k e nt h ev a l i d i t yo ft h es t u d yc o n c l u s i o na b o u tt h e
effect of the self-management education on the quality
of self-care after stroke.
Although the validity of a self-rated global assessment
scale has been criticized for its “retrospective bias”
[50,62,63], we recognized that clinical interpretation of
t h eM D Ca n dC I Ds c o r e sw o u l db ee n h a n c e di fa
patient-driven anchor were included in the study design.
Therefore, the reliable-change approach, as proposed by
Davidson and Keating [64], was adopted to expand the
clinical application of the MDC95 and CID established
by the current study. The reliable-change approach
addresses the question about the proportion of patients
exceeding the threshold of MDC and CID. The concept
is similar to the event rate, which represents the number
of people in whom an event is observed [65]. For exam-
ple, the event rate is 40% if 40 of 100 patients experi-
ence an adverse event such as side effect. On the basis
of our results, 9.5%, 6.8%, and 12.2% of patients
achieved functional improvement beyond measurement
error on the mobility, self-care, and UE function sub-
scales. The greatest proportion of patients that exceeded
the lower bound of the minimal CID was observed for
the UE function subscale (33.8%), followed by the self-
care (28.4%) and mobility (28.4%) subscales. According
to Schmitt and Fabio [66], the better the responsiveness
of a scale is, the greater the numbers of patients who
will exceed the minimal change criteria. Thus, the UE
function subscale appears the most responsive subscale
among those in the physical category of the SS-QOL for
the patients of this study. Because the focus of the reha-
bilitation used in the current study was on the func-
tional recovery of the paretic arm, it is also possible that
the intervention effect was responsible for the relatively
greater proportion of patients who exceeded the MDC
and CID of the UE function subscale. Further research
using larger samples is needed to validate the findings.
It is important to note that the participants included
in this study were assigned to receive different treatment
programs; thus, the variance in the change scores might
Table 2 Threshold values of the MDC95 and clinically important difference (CID) of the SS-QOL subscales
Subscale Score range ICC (95% CI) MDC95 (% scale width) Distribution-based CID Anchor-based CID
(% scale width)
0.5 SD (% scale width) 1 SEM (% scale width)
Mobility 6-30 0.84 (0.63, 0.93) 5.9 (24.6%) 2.4 (10%) 1.7 (7.1%) 1.5 (6.3%)
Self-care 5-25 0.88 (0.73, 0.95) 4.0(20.0%) 1.9 (9.5%) 1.2 (6.0%) 1.3 (6.5%)
UE function 5-25 0.88 (0.72, 0.95) 5.3(26.5%) 1.8 (9.0%) 1.3 (6.5%) 1.2 (6.0%)
Abbreviations: CI, confidence interval; ICC, intraclass correlation coefficient; MDC95, minimal detectable change at 95% confidence; SD, standard deviation; SEM,
standard error of measurement; UE, upper extremity.
Table 3 Number of participants who met the criteria of
the MDC95 and clinically important difference (CID)
Subscale MDC95 Distribution-based CID Anchor-based CID
0.5 SD 1 SEM
No. (%) No. (%) No. (%) No. (%)
Mobility 7 (9.5%) 15 (20.3%) 21 (28.4%) 21 (28.4%)
Self-care 5 (6.8%) 21 (28.4%) 21 (28.4%) 21 (28.4%)
UE function 9 (12.2%) 25 (33.8%) 25 (33.8%) 25 (33.8%)
Abbreviations: MDC95, minimal detectable change at 95% confidence; SD,
standard deviation; SEM, standard error of measurement; UE, upper extremity.
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tional analyses of the CIDs for each intervention group
showed that the differences in CID values represented
by 1 SEM between the participants of each intervention
group and the overall participants were less than 0.6
points in the mobility subscale (each intervention parti-
cipants: 1.3-2.3; vs. overall participants: 1.7) and 0.4
point in the self-care (1.1-1.6 vs. 1.2) and UE function
subscales (1.1-1.7 vs. 1.3); and the differences in CID
values represented by 0.5 SD between each intervention
group participants and the overall participants were less
than 0.7 points (mobility: 1.8-3.1 vs. 2.4, self-care:
1.6-2.4 vs. 1.9, and UE function: 1.6-2.5 vs. 1.8). Gener-
ally speaking, the CID values in each intervention group
are arguably close enough to allow collapse of data from
all intervention groups into one group for analysis in
each subscale. Given the above information and the fact
that the same amount of treatment duration and inten-
sity were used across the different treatment programs,
we felt the method of collapsing the data from various
intervention groups would be justifiable. For example,
some recent studies [67,68] have combined the data
from different intervention groups for clinimetric
analyses.
The current investigation has some limitations that
warrant consideration when interpreting and generaliz-
ing the study findings. First, the generalizability of the
c u r r e n tf i n d i n g sm i g h tb el i m i t e d .B e c a u s ew eo n l y
included patients from departments of rehabilitation
with the demonstration of Brunnstrom stage III or
higher for the affected UE, the current findings may not
be suitable for stroke patient at a Brunnstrom stage of
less than III. In addition, some patients were excluded
from the current investigation due to cognitive difficul-
ties. To increase the external validity of the results of
this study, it is warranted to recruit a wider sample of
patients with stroke with differing levels of motor
impairment and cognitive difficulty.
Second, because of the relevance of proxy reports for
QOL outcome evaluations, particularly in patients with
stroke with language impairments [69], there is a need
for extended research on the clinimetric properties of
the proxy version of the SS-QOL to establish the mini-
mal significant change perceived by the proxies.
Third, although patients who have received different
treatment programs with the same treatment duration
are often pooled together for clinimetric analysis of the
outcome measures [67,68], further research is needed
that may investigate the MDC and CID of the SS-QOL
for specific interventions based on larger samples to
provide further insights into the clinimetric properties
of the SS-QOL in specific contexts.
Finally, there are potential clinimetric differences in
patient-reported QOL outcomes due to the modes of
administration [70]; thus, further research may study
clinimetric attributes of the SS-QOL administered in
different modes, such as paper-and-pencil administra-
tion vs. telephone interviews vs. Web-based electronic
data collection.
Conclusions
In addition to providing information about the psycho-
metric properties of the SS-QOL subscales, the preli-
minary results of the MDC and CID of the SS-QOL
subscales established by this study facilitate the inter-
pretation of the change scores observed in patients
with stroke receiving rehabilitation therapies. We
found that a patient’s change score has to reach 5.9
(24.6% scale width) on the SS-QOL mobility, 4.0
(20.0% scale width) on the self-care, and 5.3 (26.5%
scale width) on the UE function subscales to indicate a
true and reliable improvement. If the mean change
scores for the SS-QOL subscales within a stroke
patient group are 1.5 to 2.4 (6.3% to 10% scale width)
for mobility, 1.2 to 1.9 (6.0% to 9.5% scale width) for
self-care, and 1.2 to 1.8 (6.0% to 9.0% scale width) for
UE function, the changes may be considered clinically
important. According to the proportions of patients
who met the MDC and CID criteria, the UE function
subscale seems more responsive than the mobility and
self-care subscales for the patients of this study. This
may be related to the nature of the rehabilitation
therapies involved in our research (i.e., physical inter-
ventions that emphasized UE function). Findings of the
present study warrant further study based on larger
samples involving different types of stroke rehabilita-
tion programs.
Acknowledgements
This research was supported in part by grants from the National Science
Council (NSC-97-2314-B-002-008-MY3, NSC-97-2314-B-182-004-MY3, NSC-97-
2811-B-002-101, and NSC-98-2811-B-002-073) and the National Health
Research Institutes (NHRI-EX99-9920PI and NHRI-EX99-9742PI).
Author details
1School of Occupational Therapy, College of Medicine, National Taiwan
University, 17, F4, Xu Zhou Road, Taipei, Taiwan.
2Division of Occupational
Therapy, Department of Physical Medicine and Rehabilitation, National
Taiwan University Hospital, 7 Chung-shan South Road, Taipei, Taiwan.
3Department of Occupational Therapy and Graduate Institute of Clinical
Behavioral Science, Chang Gung University, 259 Wenhua 1st Road, Taoyuan,
Taiwan.
4Institute of Biophotonics, National Yang-Ming University and
Department of Ophthalmology, Taipei City Hospital-Heping Branch, Taipei,
Taiwan.
Authors’ contributions
KCL conceived the study, participated in its design and coordination, and
helped to draft the manuscript. TF participated in the design of the study,
performed the statistical analysis, and participated in the writing of the
manuscript. CYW contributed to secure the research funding, designed and
conducted the study, and participated in the data interpretation. CJH
contributed to the revision of the manuscript. All authors read and
approved the final manuscript.
Lin et al. Health and Quality of Life Outcomes 2011, 9:5
http://www.hqlo.com/content/9/1/5
Page 6 of 8Competing interests
The authors declare that they have no competing interests.
Received: 15 June 2010 Accepted: 19 January 2011
Published: 19 January 2011
References
1. Lavados PM, Hennis AJM, Fernandes JG, et al: Stroke epidemiology,
prevention, and management strategies at a regional level: Latin
America and the Caribbean. Lancet Neurol 2007, 6:362-372.
2. Mar J, Sainz-Ezkerra M, Moler-Cuiral JA: Calculation of prevalence
estimates through differential equations: application to stroke-related
disability. Neuroepidemiology 2008, 31:57-66.
3. Muus I, Petzold M, Ringsberg KC: Health-related quality of life among
Danish patients 3 and 12 months after TIA or mild stroke. Scand J Caring
Sci 2010, 24(2):211-8.
4. Aprile I, Piazzini DB, Bertolini C, et al: Predictive variables on disability and
quality of life in stroke outpatients undergoing rehabilitation. Neurol Sci
2006, 27:40-46.
5. Dhamoon MS, Moon YP, Paik MC, et al: Long-term functional recovery
after first ischemic stroke: The Northern Manhattan study. Stroke 2009,
40:2805-2811.
6. Bowling A: Measuring Health: A Review of Quality of Life Measurement Scales.
3 edition. Maidenhead, Berkshire, England: Open University Press; 2005.
7. Carod-Artal FJ, Egido JA: Quality of life after stroke: the importance of a
good recovery. Cerebrovasc Dis 2009, 27:204-214.
8. Graham A: Measurement in stroke: activity and quality of life. In Recovery
after Stroke. Edited by: Barnes MP, Dobkin BH, Bogusslavsky J. New York:
Cambridge University Press; 2005:135-160.
9. Kissela B: The value of quality of life research in stroke. Stroke 2006,
37:1958-1959.
10. Lima RCM, Teixeira-Salmela LF, Magalhaes LC, Gomes-Neto M:
Psychometric properties of the Brazilian version of the Stroke Specific
Quality of Life Scale: application of the Rasch model. Rev Bras Fisioter
2008, 12:149-156.
11. Noble AJ, Schenk T: Which variables help explain the poor health-related
quality of life after subarachnoid hemorrhage? A meta-analysis.
Neurosurgery 2010, 66:772-783.
12. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ: Improving the
evaluation of therapeutic interventions in multiple sclerosis:
development of a patient-based measure of outcome. Health Technol
Assess 2004, 8(9).
13. Williams LS, Weinberger M, Harris LE, Clark DO, Biller J: Development of a
Stroke-Specific Quality of Life Scale. Stroke 1999, 30:1362-1369.
14. Duncan PW, Bode RK, Lai SM, Perera S: Rasch analysis of a new stroke-
specific outcome scale: the Stroke Impact Scale. Arch Phys Med Rehabil
2003, 84:950-963.
15. Salter KL, Moses MB, Foley NC, Teasell RW: Health-related quality of life
after stroke: what are we measuring? Int J Rehabil Res 2008, 31:111-117.
16. Chou PC, Chu HY, Lin JG: Effects of electroacupuncture treatment on
impaired cognition and quality of life in Taiwanese stroke patients. J
Altern Complement Med 2009, 15:1067-1073.
17. Kendall E, Catalano T, Kuipers P, Posner N, Buys N, Charker J: Recovery
following stroke: the role of self-management education. Soc Sci Med
2007, 64:735-746.
18. Muus I, Williams LS, Ringsberg KC: Validation of the Stroke Specific
Quality of Life scale (SS-QOL): test of reliability and validity of the
Danish version (SS-QOL-DK). Clin Rehabil 2007, 21:620-627.
19. Verbunt JA, Seelen HAM, Ramos FP, Michielsen BHM, Wetzelaer WL,
Moennekens M: Mental practice-based rehabilitation training to improve
arm function and daily activity performance in stroke patients: a
randomized clinical trial. BMC Neurol 2008, 8:7.
20. Ewert T, Stucki G: Validity of the SS-QOL in Germany and in survivors of
hemorrhagic or ischemic stroke. Neurorehabil Neural Repair 2007,
21:161-168.
21. Boosman H, Passier PECA, Visser-Meily JMA, Rinkel GJE, Post MWM:
Validation of the Stroke-Specific Quality of Life Scale (SS-QOL) in
patients with aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg
Psychiatry 2010, 81(5):485-9.
22. Teixeira-Salmela LF, Gomes-Neto M, Magalhaes LC, Lima RCM, Faria CDCM:
Content comparisons of stroke-specific quality of life based upon the
international classification of functioning, disability, and health. Qual Life
Res 2009, 18:765-773.
23. Portney LG, Watkins MP: Foundations of Clinical Research: Applications to
Practice. 3 edition. Upper Saddle River, NJ: Pearson/Prentice Hall; 2009.
24. Lin KC, Fu T, Wu CY, et al: Minimal detectable change and clinically
important difference of the Stroke Impact Scale in stroke patients.
Neurorehabil Neural Repair 2010.
25. Plummer P, Behrman AL, Duncan PW, et al: Effects of stroke severity and
training duration on locomotor recovery after stroke: a pilot study.
Neurorehabil Neural Repair 2007, 21:137-151.
26. Evans MD, Goldie PA, Hill KD: Systematic and random error in repeated
measurements of temporal and distance parameters of gait after stroke.
Arch Phys Med Rehabil 1997, 78:725-729.
27. Perry J, Garrett M, Gronley JK, et al: Classification of walking handicap in
the stroke population. Stroke 1995, 26:982-989.
28. Wu CY, Chuang LL, Lin KC, Chen HC, Tsay PW: Randomized trial of
distributed constraint-induced therapy versus bilateral arm training for
the rehabilitation of upper-limb motor control and function after stroke.
Neurorehabil Neural Repair 2010.
29. Lin KC, Chang YF, Wu CY, Chen YA: Effects of constraint-induced therapy
versus bilateral arm training on motor performance, daily functions, and
quality of life in stroke survivors. Neurorehabil Neural Repair 2009,
23:441-448.
30. Bouffioulx E, Arnould C, Thonnard JL: A satisfaction measure of activities
and participation in the actual environment experienced by patients
with chronic stroke. J Rehabil Med 2008, 40:836-843.
31. Brunnstrom S: Movement Therapy in Hemiplegia New York, NY: Harper &
Row; 1970.
32. Folstein MF, Folstein SE, McHugh PR: “Mini-mental State.” A practical
method for grading the cognitive state of patients for the clinician. J
Psychiatr Res 1975, 12:189-198.
33. Bohannon R, Smith M: Interrater reliability of a modified Ashworth scale
of muscle spasticity. Phys Ther 1987, 67:206-207.
34. Hsueh IP, Cheng CC, Jeng JS, Hsieh CL: Development of a scale
measuring self-perceived difficulty in performing ADL for stroke
patients. Proceedings of the Symposium of Occupational Therapy: 7 April
2005; Taipei 2005.
35. Visser-Meily JMA, Rhebergen ML, Rinkel GJE, van Zandvoort MJ, Post MWM:
Long-term health-related quality of life after aneurysmal subarachnoid
hemorrhage: Relationship with psychological symptoms and personality
characteristics. Stroke 2009, 40:1526-1529.
36. Schmitt JS, Fabio RPD: Reliable change and minimum important
difference (MID) proportions facilitated group responsiveness
comparisons using individual threshold criteria. J Clin Epidemiol 2004,
57:1008-1018.
37. de Vet HCW, Terwee CB, Knol DL, Bouter LM: When to use agreement
versus reliability measures. J Clin Epidemio 2006, 59:1033-1039.
38. Guyatt GH, Osoba D, Wu AW, et al: Methods to explain the clinical
significance of health status measures. Mayo Clin Proc 2002, 77:371-383.
39. Cohen JW: Statistical Power Analysis for the Behavior Sciences. 2 edition.
Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
40. Ringash J, O’Sullivan B, Bezjal A, Redelmeier DA: Interpreting clinically
significant changes in patient-reported outcomes. Cancer 2007, 110:196-202.
41. Norman GR, Sloan JA, Wyrwich KW: Interpretation of changes in health-
related quality of life: the remarkable universality of half a standard
deviation. Med Care 2003, 41:582-592.
42. Lang CE, Edwards DF, Birkenmeier RL, Dromerick AW: Estimating minimal
clinically important differences of upper-extremity measures early after
stroke. Arch Phys Med Rehabil 2008, 89:1693-1700.
43. Cella D, Hahn EA, Dineen K: Meaningful change in cancer-specific quality
of life scores: Differences between improvement and worsening. Qual
Life Res 2002, 11:207-221.
44. Zisapel N, Nir T: Determination of the minimal clinically significant
difference on a patient visual analog sleep quality scale. J Sleep Res 2003,
12:291-298.
45. Iyer LV, Haley SM, Watkins MP, Dumas HM: Establishing miniml clinically
important differences for scores on the pediatric evaluation of disability
inventory for inpatient rehabilitation. Phys Ther 2003, 83:888-898.
46. Hagg O, Fritzell P, Nordwall A: The clinical importance of changes in
outcome scores after treatment for chronic low back pain. Eur Spine J
2003, 12:12-20.
Lin et al. Health and Quality of Life Outcomes 2011, 9:5
http://www.hqlo.com/content/9/1/5
Page 7 of 847. Duncan PW, Wallace D, Lai SM, Johnson D, Embretson S, Laster LJ: The
Stroke Impact Scale version 2.0: evaluation of reliability, validity and
sensitivity to change. Stroke 1999, 30:2131-2140.
48. Crosby RD, Kolotkin RL, Williams GR: Defining clinically meaningful change
in health-related quality of life. J Clin Epidemiol 2003, 56:395-407.
49. Santanello NC, Zhang J, Seidenberg B, Reiss TF, Barber BL: What are
minimal important changes for asthma measures in a clinical trial? Eur
Respir J 1999, 14:23-27.
50. Revicki D, Hays RD, Cella D, Sloan J: Recommended methods for
determining responsiveness and minimally important differences for
patient-reported outcomes. J Clin Epidemiol 2008, 61:102-109.
51. Hsieh YW, Wang CH, Sheu CF, Hsueh IP, Hsieh CL: Estimating the minimal
clinically important difference of the Stroke Rehabilitation Assessment of
Movement measure. Neurorehabil Neural Repair 2008, 22:723-727.
52. Fritz SL, George SZ, Wolf SL, Light KE: Participant perception of recovery
as criterion to establish important of improvement for constraint-
induced movement therapy outcome measures: a preliminary study.
Phys Ther 2007, 87:170-178.
53. Kupferberg DH, Kaplan RM, Slymen DJ, Ries AL: Minimal clinically
important difference for the UCSD Shortness of Breath Questionnaire. J
Cardiopulm Rehabil 2005, 25:370-377.
54. Wyrwich KW, Nienaber NA, Tierney WM, Wolinsky FD: Linking clinical
relevance and statistical significance in evaluating intraindividual
changes in health-related quality of life. Med Care 1999, 37:469-478.
55. Wyrwich KW, Tierney WM, Wolinsky FD: Further evidence supporting an
SEM-based criterion for identifying meaningful intraindividual changes
in health-related quality of life. J Clin Epidemiol 1999, 52:861-873.
56. Wyrwich KW, Tierney WM, Wolinsky FD: Using the standard error of
measurement to identify important changes on the Asthma Quality of
Life Questionnaire. Qual Life Res 2002, 11:1-7.
57. Jordan K, Dunn KM, Lewis M, Croft P: A minimal clinically important
difference was derived for the Roland-Morris Disability Questionnaire for
low back pain. J Clin Epidemiol 2006, 59:45-52.
58. Leidy NK, Wyrwich KW: Bridging the gap: Using triangulation
methodology to estimate minimal clinically important differences
(MCIDs). COPD 2005, 2:157-165.
59. Cella D, Bullinger M, Scott C, Barofsky I: Group vs. individual approaches
to understanding the clinical significance of differences or changes in
quality of life. Mayo Clin Proc 2002, 77:384-392.
60. Dawson J, Doll H, Coffey J, Jenkinson C: Responsiveness and minimally
important change for the Manchester-Oxford foot questionnaire
(MOXFQ) compared with AOFAS and SF-36 assessments following
surgery for hallux valgus. Osteoarthritis Cartilage 2007, 15:918-931.
61. Resnik L, Dobrykowski E: Outcomes measurement for patients with low
back pain. Orthop Nurs 2005, 24:14-24.
62. Norman G, Stratford P, Regehr G: Methodological problems in the
retrospective computation of responsiveness to change: the lessons of
Cronbach. J Clin Epidemiol 1997, 50:869-879.
63. Schwartz N, Sudman S: Autobiographical memory and the validity of
retrospective reports New York: Springer-Verlag; 1994.
64. Davidson M, Keating JL: A comparison of five Low Back Disability
Questionnaires: reliability and responsiveness. Phys Ther 2002, 82:8-24.
65. Barratt A, Wyer PC, Hatala R, et al: Tips for teachers of evidence-based
medicine: 1. Relative risk reduction, absolute risk reduction and number
needed to treat. CMAJ 2004, 171:353-358.
66. Schmitt JS, Di Fabio RP: Reliable change and minimum important
difference (MID) proportions facilitated group responsiveness
comparisons using individual threshold criteria. J Clin Epidemiol 2004,
57:1008-1018.
67. Faber J, Bosscher RJ, van Wieringen PC: Clinimetric properties of the
performance-oriented mobility assessment. Phys Ther 2006, 86:944-954.
68. Twiss J, Doward LC, McKenna SP, Eckert B: Interpreting scores on multiple
sclerosis-specific patient reported outcome measures (the PRIMUS and
U-FIS). Health Qual Life Outcome 2010, 8:117.
69. Williams LS, Bakas T, Brizendine E, et al: How valid are family proxy
assessments of stroke patients’ health-related quality of life? Stroke 2006,
37:2081-2085.
70. Gundy CM, Aaronson NK: Effects of mode of administration (MOA) on the
measurement properties of the EORTC QLQ-C30: a randomized study.
Health Qual Life Outcomes 2010, 8:35.
doi:10.1186/1477-7525-9-5
Cite this article as: Lin et al.: Assessing the Stroke-Specific Quality of
Life for Outcome Measurement in Stroke Rehabilitation: Minimal
Detectable Change and Clinically Important Difference. Health and
Quality of Life Outcomes 2011 9:5.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Lin et al. Health and Quality of Life Outcomes 2011, 9:5
http://www.hqlo.com/content/9/1/5
Page 8 of 8